Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREW J ARMSTRONG

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1528160199
CMS profile
833679
Location
DURHAM, NC

General Payments · PY2018–2024

$320,413.22

  • Reported across 211 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$39,548.57

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $42,930.51 38
PY2019 $47,178.14 50
PY2020 $38,211.94 23
PY2021 $52,534.92 18
PY2022 $38,807.56 23
PY2023 $61,201.58 28
PY2024 $39,548.57 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma Global Development $1,860.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1132966129 CMS
Astellas Pharma Global Development $31.96 06/03/2024 Food and Beverage Undisputed 01/23/2026 1132965905 CMS
AstraZeneca Pharmaceuticals LP $26.14 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105824289 CMS
AstraZeneca Pharmaceuticals LP $47.28 06/02/2024 Food and Beverage Undisputed 01/23/2026 1104460356 CMS
AstraZeneca UK Limited $685.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 1093982136 CMS
AstraZeneca UK Limited $1,370.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 1093889082 CMS
AstraZeneca UK Limited $4,110.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 1093937730 CMS
Bayer Healthcare Pharmaceuticals Inc. $476.25 03/27/2024 Consulting Fee Undisputed 01/23/2026 1086245636 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,905.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1086176060 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,053.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 1086226174 CMS
Dendreon Pharmaceuticals LLC $14.91 11/22/2024 Food and Beverage Undisputed 01/23/2026 1149312160 CMS
Exelixis Inc. $136.78 01/26/2024 Food and Beverage Undisputed 01/23/2026 1138555162 CMS
Exelixis Inc. $2,040.00 02/29/2024 Honoraria Undisputed 01/23/2026 1138555164 CMS
Merck Sharp & Dohme LLC $1,830.00 02/12/2024 Consulting Fee Undisputed 01/23/2026 1141627989 CMS
Merck Sharp & Dohme LLC $4,270.00 04/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141628087 CMS
Merck Sharp & Dohme LLC $15.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1141578916 CMS
Merck Sharp & Dohme LLC $15.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1141578918 CMS
Merck Sharp & Dohme LLC $4,270.00 06/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141627991 CMS
Merck Sharp & Dohme LLC $2,135.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1141628089 CMS
Merck Sharp & Dohme LLC $150.00 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1141628091 CMS
Novartis Pharmaceuticals Corporation $26.82 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086763365 CMS
Novartis Pharmaceuticals Corporation $20.44 12/04/2024 Food and Beverage Undisputed 01/23/2026 1086763367 CMS
PFIZER INC. $7,300.00 01/29/2024 Consulting Fee Undisputed 01/23/2026 1131169832 CMS
PFIZER INC. $730.00 04/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131310617 CMS
PFIZER INC. $145.96 04/28/2024 Food and Beverage Undisputed 01/23/2026 1131557106 CMS
PFIZER INC. $2,920.00 05/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131412503 CMS
PFIZER INC. $135.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1131444323 CMS
PFIZER INC. $147.14 09/15/2024 Food and Beverage Undisputed 01/23/2026 1132026557 CMS
PFIZER INC. $139.46 12/08/2024 Food and Beverage Undisputed 01/23/2026 1131261517 CMS
Sumitomo Pharma America, Inc. $42.43 06/01/2024 Food and Beverage Undisputed 01/23/2026 1148822243 CMS
Telix Pharmaceuticals $1,500.00 01/23/2024 Consulting Fee Undisputed 01/23/2026 1081981616 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.